TESARO announces updates to U.S. prescribing iInformation for VARUBI® (rolapitant)
TESARO announced it has updated the VARUBI® (rolapitant) injectable emulsion package insert in collaboration with the FDA. VARUBI injectable emulsion is a substance P/neurokinin receptor antagonist indicated for prevention of delayed nausea and vomiting associated with chemotherapy in adults. January 12, 2018
